Insider · CIK 0002079922
Robert Charles Swanton
director
Files at BCYC (BICYCLE THERAPEUTICS PLC). First filing Oct 6, 2026, latest Oct 6, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $12k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BCYC: BICYCLE THERAPEUTICS PLC
BCYCOct 9, 2026 · close 3.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | BICYCLE THERAPEUTICS PLC | $12k 3,431 shares | -18% | 0% from low-62% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | BCYC BICYCLE THERAPEUTICS PLC | SOpen-market sale Ordinary Shares | -3,431 | $3.47 | $12k | 15,782 | 6 d ago |
| Aug 12, 2025 | BCYC BICYCLE THERAPEUTICS PLC | AGrant or award Ordinary Shares | +12,500 | $0.00 | $0 | 15,589 | Aug 14, 2025 |
| Aug 12, 2025 | BCYC BICYCLE THERAPEUTICS PLC | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Aug 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.